Study: Nanoparticle shrinks tumor size by 80% in mouse model

This article was originally published here

Mayo ClinicResearchers from the Mayo Clinic have developed a type of cancer-fighting nanoparticle that is designed to shrink breast cancer tumors and prevent recurrence. In a mouse model, the therapy yielded a 70-80% reduction in tumor size and mice treated with the nanoparticles demonstrated resistance to future tumor recurrence a month later.

The nanoparticle is coated with antibodies that target the HER2 receptor – a molecule found on 40% of breast cancers. The particles target tumors by recognizing HER2 and triggering the immune cells to attack the tumor cells.

Get the full story at our sister site, Drug Delivery Business News.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply